The Role of Activin Receptor-Like Kinase 1 Signaling in the Pulmonary Vasculature of Experimental Diaphragmatic Hernia

被引:4
|
作者
Hofmann, Alejandro Daniel [1 ,2 ]
Zimmer, Julia [1 ]
Takahashi, Toshiaki [1 ]
Gosemann, Jan-Hendrik [1 ,2 ]
Puri, Prem [1 ]
机构
[1] Our Ladys Hosp Sick Children, Natl Childrens Res Ctr, Carl Neuberg Str 1, Dublin 30625, Ireland
[2] Hannover Med Sch, Dept Pediat Surg, Hannover, Germany
关键词
CDH; nitrofen; activin receptor-like kinase 1; pulmonary hypertension; vascular remodeling; EXPRESSION; HYPERTENSION; CAVEOLIN-1; PATHWAY; ROSIGLITAZONE; ACTIVATION; ENDOGLIN; PROTEIN; TARGET; GROWTH;
D O I
10.1055/s-0035-1566105
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
AimThe high morbidity and mortality in newborn infants diagnosed with congenital diaphragmatic hernia (CDH) is widely recognized to be due to pulmonary hypoplasia and persistent pulmonary hypertension (PH). The underlying structural and molecular pathomechanisms causing PH are not fully understood. Recently, activin receptor-like kinase 1 (ALK-1), an endothelial cell (EC) receptor, has been implicated in the pathogenesis of PH. ALK-1 transmits signals via a Smad pathway stimulating EC proliferation and migration leading to structural lung remodeling consecutively resulting in PH. Increased pulmonary expression of ALK-1 has been reported in patients with severe PH as well as in experimental models of PH. We designed this study to investigate the hypothesis that pulmonary ALK-1 expression is increased in nitrofen-induced CDH. MethodsPregnant rats were exposed to nitrofen or vehicle on D9. Fetuses were sacrificed on D21 and divided into nitrofen (n=16) and control group (n=16). Quantitative real-time polymerase chain reaction, Western blotting, and confocal-immunofluorescence microscopy were performed to determine pulmonary gene and protein expression as well as vascular localization of expressed ALK-1. ResultsPulmonary gene expression levels of ALK-1 were significantly upregulated in nitrofen-treated lung tissue compared with controls. Western blotting showed increased pulmonary protein expression for ALK-1 in the CDH group when compared with control lung tissue. Confocal microscopy demonstrated markedly increased medial and adventitial thickness of pulmonary arteries in the CDH group and revealed increased ALK-1 protein expression of the pulmonary vasculature of CDH pups compared with controls. ConclusionUpregulated gene and increased protein expression of ALK-1 in the pulmonary vasculature of nitrofen-induced CDH suggest that increased expression of ALK-1 may play a crucial role in the molecular pathogenesis of vascular remodeling induced PH in experimental CDH.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 50 条
  • [31] Bound by Fate: The Role of Reactive Oxygen Species in Receptor-Like Kinase Signaling
    Kimura, Sachie
    Waszczak, Cezary
    Hunter, Kerri
    Wrzaczek, Michael
    PLANT CELL, 2017, 29 (04): : 638 - 654
  • [32] CLONING AND CHARACTERIZATION OF THE MURINE ACTIVIN RECEPTOR-LIKE KINASE-1 (ALK-1) HOMOLOG
    WU, XY
    ROBINSON, CE
    FONG, HW
    CRABTREE, JS
    RODRIGUEZ, BR
    ROE, BA
    GIMBLE, JM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (01) : 78 - 83
  • [33] Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphragmatic hernia
    Jan-H Gosemann
    Florian Friedmacher
    Manuela Hunziker
    Luis Alvarez
    Nicolae Corcionivoschi
    Prem Puri
    Pediatric Surgery International, 2013, 29 : 3 - 8
  • [34] Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice
    Gonzalez-Nunez, Maria
    Riolobos, Adela S.
    Castellano, Orlando
    Fuentes-Calvo, Isabel
    de los Angeles Sevilla, Maria
    Oujo, Barbara
    Pericacho, Miguel
    Cruz-Gonzalez, Ignacio
    Perez-Barriocanal, Fernando
    ten Dijke, Peter
    Lopez-Novoa, Jose M.
    DISEASE MODELS & MECHANISMS, 2015, 8 (11) : 1427 - 1439
  • [35] Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
    Johnson, DW
    Berg, JN
    Baldwin, MA
    Gallione, CJ
    Marondel, I
    Yoon, SJ
    Stenzel, TT
    Speer, M
    PericakVance, MA
    Diamond, A
    Guttmacher, AE
    Jackson, CE
    Attisano, L
    Kucherlapati, R
    Porteous, MEM
    Marchuk, DA
    NATURE GENETICS, 1996, 13 (02) : 189 - 195
  • [36] Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
    Cunha, Sara I.
    Pardali, Evangelia
    Thorikay, Midory
    Anderberg, Charlotte
    Hawinkels, Lukas
    Goumans, Marie-Jose
    Seehra, Jasbir
    Heldin, Carl-Henrik
    ten Dijke, Peter
    Pietras, Kristian
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (01): : 85 - 100
  • [37] Two Rare Conditions Linked By An Activin Receptor-Like Kinase 1 (alk-1) Mutation
    McCambridge, A.
    Cartin-Ceba, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [38] Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure
    Morine, Kevin J.
    Qiao, Xiaoying
    Paruchuri, Vikram
    Aronovitz, Mark J.
    Mackey, Emily E.
    Buiten, Lyanne
    Levine, Jonathan
    Ughreja, Keshan
    Nepali, Prerna
    Blanton, Robert M.
    Oh, S. Paul
    Karas, Richard H.
    Kapur, Navin K.
    CARDIOVASCULAR PATHOLOGY, 2017, 31 : 26 - 33
  • [39] Three novel mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic teleangiectasia
    Assis, A
    Ozelo, MC
    Annichino-Bizzacchi, JM
    Costa, FF
    Arruda, VR
    THROMBOSIS AND HAEMOSTASIS, 1999, : 341 - 341
  • [40] Prevalence of bone morphogenetic protein receptor type II and activin receptor-like kinase-1 gene mutation in pulmonary arterial hypertension
    Nakanishi, N
    Kyotani, S
    Oya, H
    Nitoube, J
    Morisaki, H
    Morisaki, T
    CIRCULATION, 2004, 110 (17) : 719 - 719